No. of pages:
Jim Mellon is an investor with an interest in several industries. After studying PPE at Oxford, Jim worked in Asia and in the US for two fund management companies, GT Management and Thornton & Co, before establishing his own business in 1991. This business is now known by two names - Charlemagne Capital, recently acquired, and Regent Pacific Group, listed in Hong Kong. Jim's private investment ... Read more on Jim Mellon
Al Chalabi is an entrepreneur and business advisor with a diverse professional background. He grew up in the UK and studied Aeronautical Engineering at the University of Southampton. Al started his career in Canada, working as an engineer in process automation systems. After his MBA, he worked as a management consultant, specialising in technology, strategy and operations, based out of Hong Kong. ... Read more on Al Chalabi
Jim Mellon and Al Chalabi have once again written a gold standard guide to investing in a key emerging area of technology.Read more
... I read Juvenescence, a new book by Jim Mellon and Al Chalabi. The authors are not interested in fairly tales: they are successful money men, and their book is an overview of what life science ...Read more
Watch this video to see Jim talk about inflation and also his new book - Juvenescence.Read more
‘We are all going to live longer, so why not invest in it?’ seems to be the premise of Jim Mellon and Al Chalabi’s new book, Juvenescence – Investing in the Age of Longevity. Mellon and ...Read more
Isle of Man Today
Isle of Man based businessman Jim Mellon was at the launch of his latest book, ’Juvenescence’, at the Oxford and Cambridge Club in London.
Jim, who the Sunday Times Rich List estimates as ...
‘We are on the verge of a lifespan revolution. Life expectancy is going to rise to between 110 and 130 in the next 30 years. This is not science fiction.”
Jim Mellon’s vision may be ...
Life expectancy has doubled in just a few generations, and the trend will continue, Jim Mellon tells Merryn Somerset Webb. That’s an opportunity for investors.
Want to live forever? I’m not ...